- Home
- QNCX vs SUNS Comparison
QNCX vs SUNS Comparison
Compare QNCX & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SUNS
- Stock Information
- Founded
- QNCX 2012
- SUNS 2023
- Country
- QNCX United States
- SUNS United States
- Employees
- QNCX 36
- SUNS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SUNS Real Estate Investment Trusts
- Sector
- QNCX Health Care
- SUNS Real Estate
- Exchange
- QNCX Nasdaq
- SUNS Nasdaq
- Market Cap
- QNCX 139.2M
- SUNS 128.7M
- IPO Year
- QNCX 2019
- SUNS N/A
- Fundamental
- Price
- QNCX $2.68
- SUNS $10.28
- Analyst Decision
- QNCX Strong Buy
- SUNS Strong Buy
- Analyst Count
- QNCX 4
- SUNS 3
- Target Price
- QNCX $7.75
- SUNS $13.50
- AVG Volume (30 Days)
- QNCX 551.1K
- SUNS 62.3K
- Earning Date
- QNCX 11-12-2025
- SUNS 11-13-2025
- Dividend Yield
- QNCX N/A
- SUNS 11.66%
- EPS Growth
- QNCX N/A
- SUNS 1112.46
- EPS
- QNCX N/A
- SUNS 1.09
- Revenue
- QNCX N/A
- SUNS $19,384,703.00
- Revenue This Year
- QNCX N/A
- SUNS $183.25
- Revenue Next Year
- QNCX N/A
- SUNS $62.46
- P/E Ratio
- QNCX N/A
- SUNS $9.43
- Revenue Growth
- QNCX N/A
- SUNS 2540.16
- 52 Week Low
- QNCX $0.72
- SUNS $7.80
- 52 Week High
- QNCX $2.85
- SUNS $15.70
- Technical
- Relative Strength Index (RSI)
- QNCX 83.72
- SUNS 62.72
- Support Level
- QNCX $1.61
- SUNS $9.29
- Resistance Level
- QNCX $1.84
- SUNS $9.83
- Average True Range (ATR)
- QNCX 0.21
- SUNS 0.32
- MACD
- QNCX 0.10
- SUNS 0.11
- Stochastic Oscillator
- QNCX 87.94
- SUNS 99.15
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.